Pharmaceutical Janssen . .Xarelto package insert; 2013 Available from. [Last accessed on 2013 Oct, 31 : .
Administration Drug . .. United States. c2013 Xarelto Medication Guide, : .
. .?curl=pages/ m e d i c i n e s / h u m a n / m e d i c i n e s / 0 0 0 9 4 4 / h u m a n _ med_001155.jsp [Last accessed on 2013 June]. European Union. C2013 Xarelto Public Assessment Report, : .
'Gara O,Kushner PT,Ascheim FG,Casey DD,Chung DE,de Lemos MK,JA MK .2013 .American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for management of ST‑elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 127 : 362-425.
Administration Drug . .Development and Drug Approval Process. htm [Last accessed on 2013 Oct, 31 : .
Medicines European . .Over view. WC0b01ac0580028a43. [Last accessed on 2013 Oct, 31 : .
Downing NS,Aminawung JA,Shah ND,Braunstein JD,Krumholz HW,Ross JS .2012 .Regulatory review of novel therapeutics‑ comparison of three regulatory agencies. N Engl J Med, 367 : 1165-7.
Gidron M,Hollis C,Jones E. European Medicines Agency Do Not Mirror FDA. FDL C .2008 .. , 805 : 1-12.
Administration Drug . .. htm [Last accessed on 2013 Oct, 31 : .
Mega JL,Braunwald E,Wiviott SD,Bassand JP,Bhatt DL,Bode C .2012 .Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med, 366 : 9-19.
Administration Drug . .FDA Briefing Document for the Cardiovascular and Renal Drugs Advisory Committee (CRDAC) for Xarelto® (Rivaroxaban) oral tablets c 2012 Available from. page=192 [Last accessed on 2013 Oct, 31 : .
.2013 .Drug approval processes: A case study of rivaroxaban. Arch Pharma Pract, 4 : 186-9.